U.S. Markets closed

The Cassava Saga: Here's What You Need To Know About This Embattled Alzheimer's Stock

·6 min read
The Cassava Saga: Here's What You Need To Know About This Embattled Alzheimer's Stock
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Cassava Sciences could hold the holy grail in Alzheimer's treatment. But once-highflying SAVA stock has plummeted this year.